chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 12:45pm, patient began to have headache. No blurry vision. No N/V/SOB. 7/10 in pain, known to have headaches in medical history. Vitals stable 117/52, HR 74, O2 97%, FS 100
difficulty speaking... hesitancy. Fuzzy thinking. Dizzy. Achy. Laying down and watching TV was about all I could do. constipated Started when I awoke and was mostly done by 5 PM The next day I spent quite a bit of time on toilet.
Cystic Fibrosis exacerbation, Bronch obstruction, Acute Kidney Failure
Information has been received from a registered nurse concerning a 9 year old white male with no allergies or medical history who on 3/18/97 was vaccinated SC with a first dose of varicella virus vaccine live (lot # 621065/1543D). There was no concomitant medication. On 7/9/04, the patient experienced lesions on most of body, especially the shoulders, chest, and back. He was noted to be afebrile. Unspecified medical attention was sought and he was treated with calamine (+) camphor (+) praxomine hydrochloride baths and diphenhydramine hydrochloride. A product quality complaint was not involved. Follow up information was received from the registered nurse who indicated that the father called the physician's office stating that the patient had chicken pox on 7/12/04. The mother brought the patient to the physician's office on 7/13/04 to confirm chicken pox. It was noted that the adverse event began on 7/9/04. The chicken pox was resolving as of 7/16/04. It was also noted that the patient recovered. No diagnostic laboratory tests were performed. The patient had no adverse events following prior vaccination. No further information is expected.
This spontaneous report as received from a physician refers to a 83 year old male patient with allergy to penicillin and history of lung cancer. On 25-JAN-2008 the patient was vaccinated with a dose of ZOSTAVAX (lot#, dose, route not reported). Concomitant medications were not provided. On 24-MAR-2014 the patient developed shingles. The patient was given VALTREX for treatment. No lab diagnostics studies were performed. The outcome of shingles was reported as recovered on an unspecified date in 2014. Additional information is not expected because the reporter did not want to be contacted.
Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Patient had cough, no taste, no smell, fever, headache and was tired due to COVID.  Treatment medications included over the counter pain relievers and unspecified cough medicine.
SWELLING IN BILATERAL LOWER EXTREMETIES, FACIAL EDEMA AND HANDS, UTI,  NEW ONSET ANEMIA, LEGS FELT LIKE THEY WERE GOING TO POP AND SOME SOB
neurological/ cognitive changes- memory related. unable to recall known location in home; misnamed colors known for a long time; forgot location of food items etc.
head heaviness; felt like fainting; chest heaviness; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (78 unit unspecified) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) via unspecified route of administration on unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if she can get the 2nd dose of the vaccine since she was experiencing few side effects, head heaviness, felt like fainting, chest heaviness. The patient was unsure if it was due to vaccine. The outcome of the events head heaviness, felt like fainting, chest heaviness was unknown.  Follow-up activities are possible, information on the batch number has been requested.
I had the 2 shot one and I still got shingles/ suspected vaccination failure; I had the 2 shot one and I still got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient reported case for herself/himself. The age at vaccination was not reported. The age group was not reported, however it was captured as an adult as per vaccine indication. The patient stated that he/she had the 2 shot one and still got shingles. This case was considered to be a suspected vaccination failure case, as the details regarding being full vaccination schedule, laboratory confirmation for shingles and exact time to onset were unknown.
Headache, Fever, Erythema/ enduration at injection site  Narrative:
Pt  received a flu shot 10/4/09. She had increased arm pain for the following 12 days. Her left arm is almost imobile. Pt saw MD 10/16/09 and MD indicated possible tendon injury or other complications including infection. Pt has scheduled MRI, X-ray, and blood work scheduled.
Patient is a 58-year-old female who presents with complaint of left upper arm pain and weakness ever since December 5 and she received a flu shot in that arm. It's been now almost 2 months. She states that she can move her shoulder well but if she tries to lift her arm with her arm out at a slight angle it feels very weak and has a lot of pain. There is no tenderness anymore in the area but initially she had tenderness. There is no swelling or redness. She took ibuprofen for a few days which seemed to help a little bit overall it's still present. She is taking about getting a massage in the area to see if this helps.
Because of a vasovagal event at her 1st pfizer dose 11/11/21, PT was observed carefully and when she started c/o of tingling in her extremities 2 minutes after her vaccine, she responded quickly to leg elevation and supine positioning with no further progression of symptoms. BP 114/81 HR 97   PO2 100%   She remained stable and sat up after 15 minutes, then walked without problems in another 15 minutes. She was discharged with Mom and older sibling without further incident.
Patient was assessed after 15 min. Patient was complaining of dizziness. Patients vitals were obtained. Patients blood pressure was 92/57. Patient was given water and waited another 15 min. Patients blood pressure was reobtained and was then 98/58, Patient was given more water and was assessed again after another 15 min. Patients blood pressure was then 102/72. Patient was assessed again after another 15 min. Patients blood pressure is now 108/80.
I24.8 DEMAND ISCHEMIA 12/14/2022 PROPHYLACTIC MEDICATION PRESCRIPTION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 PROPHYLACTIC MEDICATION PRESCRIPTION
12-5. Awoke not able to move both shoulders weakness progressed down both arms and to hands. 12-8 -L foot became numb and would 'give out' then developed pain in left foot. 12-12 - R knee weakness and 'giving out'. 12-13 - L facial numbness and weakness.
11/3/2006 NOON - HIVES ON FACE, QUICKLY SPREAD TO NECK.  DULL HEADACHE. 11/3/2006 1:30 PM - HIVES ON RIGHT WRIST. 11/3/2006 3:30 PM - HIVES ON WRIST AND NECK IMPROVE. 11/3/2006 5:30 PM AND 10:00 PM - TOOK ACETAMINOPHEN. 11/4/2006 12:00 AM - HIVES ON FACE, NECK, WRIST REAPPEAR.  SWEATING. 11/4/2006 7:00 AM - HIVES GONE. INTERMITTENT HEADACHE.  FATIGUE, NAUSEA, MALAISE. 11/4/2006 10:00 AM - TOOK "AIRBORNE"
RASHES ALL THE BODY,GETTING WORSE AND STARTED ON ARM, LEG, NECK AND FACE; ITCHY; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number were not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced rashes all the body, getting worse and started on arm, leg, neck and face. On MAR-2021, the subject experienced itchy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rashes all the body,getting worse and started on arm, leg, neck and face, and the outcome of itchy was not reported. This report was non-serious.
Hives, rash, itching tight feeling in throat, trouble swallowing( Anaphylactic reaction) 340pm vaccine given, 740pm woke up with symptoms went to emergency room arrived approximately 810pm MD ordered IV Solu-Medrol, 1 L normal saline, famotidine, PO Benadryl, with good effects and complete resolution of symptoms monitor for couple hrs released
This case was reported by a pharmacist via call center representative and described the occurrence of numbness of upper extremities in a 58-year-old female patient who received SHINGRIX (batch number 4LH35, expiry date 11th September 2021) for prophylaxis. Concomitant products included SHINGRIX. On 5th April 2019, the patient received the 2nd dose of SHINGRIX. In April 2019, less than a week after receiving SHINGRIX, the patient experienced numbness of upper extremities, weakness of upper extremities and injection site reaction. On an unknown date, the outcome of the numbness of upper extremities, weakness of upper extremities and injection site reaction were unknown. It was unknown if the reporter considered the numbness of upper extremities, weakness of upper extremities and injection site reaction to be related to SHINGRIX. Additional details were provided as follows: The patient did not had reaction with the 1st dose of SHINGRIX vaccine. The patient received SHINGRIX in the left deltoid. At the time of reporting, the patient was experiencing numbness of upper extremities, muscle weakness upper limb and these was described as injection site reaction sized about 2 inches by 4 inches.
Chills, nausea, diarrhea, dizziness, fatigue, brain fog, blurry vision, poor depth perception and headaches.
Information has been received from a physician concerning an 18 year old female who was vaccinated with GARDASIL (route and site not reported).  On 20-FEB-2008, 22-APR-2008 and 21-OCT-2008, the patient was given the first, second and third dose of GARDASIL separately.  There were no adverse effects after the first 2 doses.  About 2 days after her last dose of GARDASIL, the patient experienced intermittent episodes of "tingling" in her toes, fingers, and face that last between 30 minutes and 1 hour then resolved.  Complete blood panel- complete blood cell count, comprehensive metabolic panel, Sedimentation rate, thyroid stimulating hormone, and Rapid Plasma Reagin done with all results normal.  The doctor had characterized this as "a skin disturbance".  The patient's tingling in her toes, fingers and face persisted.  Follow-up information was received from the physician.  She stated that this 18 year old female received her 3rd dose of GARDASIL on 21-OCT-2008 and 2 days later experienced tingling intermittently of fingertips and toes.  She stated that the episode last for about 30 minutes and were still occurring intermittently.  The patient reported one episode tingling of the face and also reported that the soles of her feet were more sensitive to touch when the tingling was not present and described the sensation as "ticklish".  The patient was not reporting any associated pain and did not experience these symptoms following dose 1 or 2.  She was concomitantly taking birth control pills since June and was recently treated for Chlamydia.  Additional information has been requested.
Sore throat; Body aches all over; Headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches all over) and HEADACHE (Headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (Sulfa). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches all over) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches all over) and HEADACHE (Headache) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.
pt recv vax; 6 hr later, became dizzy, weak, n;24-72 hr of weakness;
Swelling, redness warmth to left subcutaneous injection site are on 6-17-12. Resolved 6-19-12 swelling, warmth, redness left deltoid area. No fever or difficulty breathing. BENADRYL taken. Will follow up with a doctor.
12/25/13 - ED, c/o SOB, leukocytosis, bilat. shoulder pain at vaccine sites. WBC = 23.1. Placed on BiPAP. 12/29/13 bronchiectasis, pulm HTN, increased O2 needs. Decreased exp wheeze 12/31/13, increased anxiety, decreased breath sd, 12/31 - culture enterococcus sputum, Coag neg Staph, yeast/transferred to another hospital 1/2/14. Pneumothorax 1/31/14 - intubated due to respiratory failure ICU.
vomiting; Arm swollen significantly; This case was reported by a nurse via sales rep and described the occurrence of vomiting in a male patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero .5 ml and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced vomiting and swelling arm. On an unknown date, the outcome of the vomiting and swelling arm were unknown.   The reporter considered the vomiting and swelling arm to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 12-MAY-2022 Reporter's comment: The patient's arm was swollen significantly and experienced vomiting.  The reporter believed both were related to administration of vaccine. The reporter did not consent to follow up.
Diarrhea and body aches 3 days after vaccine. Full body aches 4 days after vaccine.
I have severe Crohn's disease, but was symptom free before my vaccine. This could be coincidental, or it might not be. About 1:30am on 2/11, I woke up in the middle of the night with severe stomach pain. When I awoke again later that morning, the pain was less, but still there. I was then progressively more and more nauseous through the day on the 11th. That night I was awoken again with severe stomach pain. The morning of the 12th I started having blood in my stool, with continued nausea and stomach pain.
Breakthrough case admission after 2 vaccines Moderna 5/12/21 Lot# 048B21A;  Moderna 6/11/21 Lot# 033C21A
ONE DAY AFTER INJECTION SITE TURNED BRIGHT RED WITH A LUMP AT SITE. SITE IS WARM TO  TOUCH.
Urinary Tract Infection, treated with Cephalexin for 5 days, symptoms stopped.  However, I received two additional doses of Pfizer and came down with UTI within days after.  First vaccine was 2/20/21.  Second was 3/13/2021.  Booster was 10/25/2021.
Not received second dose after 36 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Not received second dose after 36 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Not received second dose after 36 days). On 17-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Not received second dose after 36 days) had resolved.            Concomitant medications were not provided. Treatment information was not reported.
Pt recvd first dose of vax 21MAY91 for Hep vax & immediately felt strange, pt reported weakness, muscle spasms that lasted 2-3 wks; exp h/a & hot flashes 3 days post vax; Also devel bronchitis 3 wks post vax;
numbness on tips of 3rd & 4th fingers of lt hand; recvd 2nd Id dose in rt arm; 1APR92 f/u lost to f/u; recovery status unk;
pain and limited use shoulder and upper arm beginning day 2 after injection (high in arm) on day 9 after injection I had a 12 hour local allergic type reaction, red, hot, itching with injection site at center of about a 4" round area
Medicine was leaking out around syringe and leaking down patients' arm; Unsure if patient received full dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer or other non hcp reported that a patient unspecified age and gender (No patient identifiers were provided but the reporter has firsthand knowledge of the patient and was reporting on a specific patient) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date were not reported), via an unspecified route of administration as dose 1, single for COVID-19 immunization. The patient experienced medicine was leaking out around syringe and leaking down patient's arm and Unsure if patient received full dose. Patient was looking for recommendations. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Patient found unresponsive at home, CPR administered by EMS/ER, patient deceased.
I feel flushed; light headed; Blood pressure is 95/67; This spontaneous case was reported by an other health care professional and describes the occurrence of FLUSHING (I feel flushed), BLOOD PRESSURE ABNORMAL (Blood pressure is 95/67) and DIZZINESS (light headed) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced BLOOD PRESSURE ABNORMAL (Blood pressure is 95/67). On 30-Jan-2022, the patient experienced FLUSHING (I feel flushed) and DIZZINESS (light headed). At the time of the report, FLUSHING (I feel flushed), BLOOD PRESSURE ABNORMAL (Blood pressure is 95/67) and DIZZINESS (light headed) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, Blood pressure measurement: 95/67 Blood pressure was 95/67. In January 2022, Heart rate: 91 heart rate was 91.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Patient presented to hospital in labor on 11/25/2021. She was found to be COVID-19 positive at admission. She had fever and loss of smell during admission and required only supportive care. Patient received monoclonal antibodies during admission on 11/26/2021. Patient delivered liveborn female infant on 11/25/2021 at 40w2d. No medical history available regarding pregnancy course prior to delivery.
This case was reported by a healthcare professional and described the occurrence of swollen lymph nodes of the neck in a 1-year-old male subject who was vaccinated with PEDIARIX (GlaxoSmithKline). There were no concurrent medications. On an unspecified date about one month prior to reporting the subject received unspecified dose of PEDIARIX (unknown). One day after vaccination with PEDIARIX, the subject experienced swollen lymph nodes of the neck. It was reported that the symptom lasted for about a month, but it was also stated that the event was on-going. The subject returned to the physician for a round of antibiotics. It was noted that the physician stated that if the swelling still exists the following week, a biopsy would be planned. No further information was provided.
I personally know 9 people who died from your vaccination; This is a spontaneous report from a non-contactable consumer reporting same event under the same suspect product for 9 patients. This is one of 9 reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Reporter stated, "I personally know 9 people who died from your vaccination. You reported 16,000 people have died, even the people who work for the company speaking on this." It was unknown if autopsy was done. The outcome of the event was fatal.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101145863 Same reporter/drug/event, different patient.; Reported Cause(s) of Death: died from your vaccination
Approximately 10 cm erythema, warm firm lieft upper thigh and right thigh. Treatment: Benadryl liquid, Tylenol and ice.
About 15 minutes after vaccine starting having swelling of throat and tongue. It progressed to difficulty breathing.
Patient was given an extra dose of Hep A vaccine, patient did not have any side effects from extra dose